Vascular Actions of Angiotensin 1-7 in the Human Microcirculation: Novel Role for Telomerase

Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1254-62. doi: 10.1161/ATVBAHA.116.307518. Epub 2016 Apr 14.

Abstract

Objective: This study examined vascular actions of angiotensin 1-7 (ANG 1-7) in human atrial and adipose arterioles.

Approach and results: The endothelium-derived hyperpolarizing factor of flow-mediated dilation (FMD) switches from antiproliferative nitric oxide (NO) to proatherosclerotic hydrogen peroxide in arterioles from humans with coronary artery disease (CAD). Given the known vasoprotective properties of ANG 1-7, we tested the hypothesis that overnight ANG 1-7 treatment restores the NO component of FMD in arterioles from patients with CAD. Endothelial telomerase activity is essential for preserving the NO component of vasodilation in the human microcirculation; thus, we also tested whether telomerase activity was necessary for ANG 1-7-mediated vasoprotection by treating separate arterioles with ANG 1-7±the telomerase inhibitor 2-[[(2E)-3-(2-naphthalenyl)-1-oxo-2-butenyl1-yl]amino]benzoic acid. ANG 1-7 dilated arterioles from patients without CAD, whereas dilation was significantly reduced in arterioles from patients with CAD. In atrial arterioles from patients with CAD incubated with ANG 1-7 overnight, the NO synthase inhibitor NG-nitro-l-arginine methyl ester abolished FMD, whereas the hydrogen peroxide scavenger polyethylene glycol catalase had no effect. Conversely, in vessels incubated with ANG 1-7+2-[[(2E)-3-(2-naphthalenyl)-1-oxo-2-butenyl1-yl]amino]benzoic acid, NG-nitro-l-arginine methyl ester had no effect on FMD, but polyethylene glycol catalase abolished dilation. In cultured human coronary artery endothelial cells, ANG 1-7 significantly increased telomerase activity. These results indicate that ANG 1-7 dilates human microvessels, and dilation is abrogated in the presence of CAD. Furthermore, ANG 1-7 treatment is sufficient to restore the NO component of FMD in arterioles from patients with CAD in a telomerase-dependent manner.

Conclusions: ANG 1-7 exerts vasoprotection in the human microvasculature via modulation of telomerase activity.

Keywords: coronary artery disease; microcirculation; nitric oxide; telomerase; vasodilation.

MeSH terms

  • Adipose Tissue / blood supply*
  • Aged
  • Angiotensin I / pharmacology*
  • Arterioles / drug effects*
  • Arterioles / enzymology
  • Arterioles / physiopathology
  • Case-Control Studies
  • Cells, Cultured
  • Coronary Artery Disease / enzymology
  • Coronary Artery Disease / physiopathology
  • Coronary Vessels / drug effects*
  • Coronary Vessels / enzymology
  • Coronary Vessels / physiopathology
  • Dose-Response Relationship, Drug
  • Endothelial Cells / drug effects*
  • Endothelial Cells / enzymology
  • Enzyme Inhibitors / pharmacology
  • Female
  • Heart Atria
  • Humans
  • In Vitro Techniques
  • Male
  • Middle Aged
  • Nitric Oxide / metabolism
  • Peptide Fragments / pharmacology*
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins / agonists
  • Proto-Oncogene Proteins / metabolism
  • Receptors, G-Protein-Coupled / agonists
  • Receptors, G-Protein-Coupled / metabolism
  • Signal Transduction / drug effects
  • Telomerase / antagonists & inhibitors
  • Telomerase / genetics
  • Telomerase / metabolism*
  • Vasodilation / drug effects*
  • Vasodilator Agents / pharmacology*

Substances

  • Enzyme Inhibitors
  • Peptide Fragments
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins
  • Receptors, G-Protein-Coupled
  • Vasodilator Agents
  • Nitric Oxide
  • Angiotensin I
  • TERT protein, human
  • Telomerase
  • angiotensin I (1-7)